drugset / Trial / NCT00179231

Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia

NCT00179231

Completed 80 enrolled Vanderbilt University
RandomizedParallel-groupDouble-blindTreatment

Summary

The study involves a six-month, double-blind protocol during which eighty patients, across three sites around the country, will be randomly assigned to receive clozapine or olanzapine. The specific aims of the study are to evaluate the relative effects of olanzapine and clozapine on clinical outcomes and cognition in patients diagnosed with schizophrenia or schizoaffective disorder who have demonstrated resistance to treatment in the past.

Timeline

Start
2000-05
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clozapine Other / unclassified 564 mg
Subject Olanzapine Small molecule 34 mg